Skip to main content
Log in

Comparison of Metformin and N Acetylcysteine on Clinical, Metabolic Parameter and Hormonal Profile in Women with Polycystic Ovarian Syndrome

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Objective

Comparison of metformin and N acetylcysteine on clinical, metabolic parameter and hormonal profile in women with polycystic ovarian syndrome.

Design

Prospective comparative study.

Setting

Obstetrics and Gynecology department in Kamala Nehru Memorial Hospital Allahabad.

Patient(s)

On the basis of inclusion and exclusion criteria, 100 patients of PCOS were selected for study and assigned randomly in two groups to receive either metformin (1500 mg/day) (group M) or N acetylcysteine (1800 mg/day) (group N) for 24 weeks.

Intervention(s)

Metabolic parameter and hormonal profile were determined before and after the treatment.

Main Outcome Measure(s)

Metabolic parameters, fasting glucose, fasting insulin and testosterone changes.

Result(s)

Forty-five patients of both groups were ultimately evaluated. There was a significant improvement of body mass index, waist circumference and waist–hip ratio in group N, but there was no significant difference found in weight reduction among two groups. The biochemical marker of insulin resistance like fasting insulin, fasting glucose/insulin ratio improved significantly in group N. Greater reduction of total testosterone was observed in group N.

Conclusion(S)

Better improvement of metabolic and hormonal profile was observed in N acetylcysteine group. Because of its less side effect comparing to metformin, NAC can be used as a substitute for insulin-sensitizing agent in treatment of PCOS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rotterdam ESHRE/ASRM- Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.

    Article  Google Scholar 

  2. Wentzel P, Thunberg L, Eriksson UJ. Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture. Diabetologia. 1997;40:7–14.

    Article  CAS  PubMed  Google Scholar 

  3. Soltan-Sharifi MS, Mojtahedzadeh M, Najafi A, et al. Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms. Hum Exp Toxicol. 2007;26(9):697–703.

    Article  CAS  PubMed  Google Scholar 

  4. Fulghesu AM, Ciampelli M, Muzj G, et al. N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril. 2002;77(6):1128–35.

    Article  PubMed  Google Scholar 

  5. Gayatri K, Kumar JS, Kumar BB. Metformin and N-acetyl cysteine in polycystic ovarian syndrome—a comparative study. Indian J Clin Med. 2010;1(1):7–13.

    Google Scholar 

  6. Salehpour S, Tohidi M, Akhound MR, et al. N-acetyl cysteine, a novel remedy for poly cystic ovarian syndrome. Int J Fertil Steril. 2009;3(2):66–73.

    Google Scholar 

  7. Elnashar A, Fahmy M, Mansour A, et al. Department of obstetrics and gynecology, Benha University Hospital, Benha, Egypt. Fertil Steril. 2007;88(2):406–9.

    Article  CAS  PubMed  Google Scholar 

  8. Wei W, Zhao H, Wang A, et al. A clinical study on the short-term effect of Berberine in comparison to Metformin on the metabolic characteristics of women with polycystic ovary syndrome. Eur J Endocrinol. 2012;166:99–105.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nidhi Chandil.

Ethics declarations

Conflict of interest

There are no conflicts of interest in research involving human participants.

Ethical Approval

This study was approved by ethical committee and scientific committee of Kamala Nehru Memorial Hospital, Allahabad, where this study was conducted.

Additional information

Dr. Nidhi Chandil completed her MBBS at the G.R. Medical college, Gwalior, Madhya Pradesh, India, DGO at the M.L.B. Medical College, Jhansi, Uttar Pradesh, India, DNB at the Kamala Nehru Memorial hospital, Allahabad, Uttar Pradesh, India, and is Ex-Senior Resident in Baba Saheb Ambedkar Hospital, New Delhi, India; Dr. Shubha Pande, MBBS, MS, is a Senior Consultant at Kamala Nehru Memorial Hospital, Allahabad, Uttar Pradesh, India; Dr. Shashwati Sarkar Sen, MBBS, DNB, DGO, is a Consultant at Kamala Nehru Memorial Hospital, Allahabad, Uttar Pradesh, India; Dr. Durgesh Gupta, MBBS, MS, is a Senior Resident, IMS, BHU, Varanasi, Uttar Pradesh, India.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chandil, N., Pande, S., Sen, S.S. et al. Comparison of Metformin and N Acetylcysteine on Clinical, Metabolic Parameter and Hormonal Profile in Women with Polycystic Ovarian Syndrome. J Obstet Gynecol India 69, 77–81 (2019). https://doi.org/10.1007/s13224-018-1135-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-018-1135-3

Keywords

Navigation